Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation
Open Access
- 14 January 2024
- journal article
- research article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 167, 111263
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council
- Cancer Council SA
This publication has 19 references indexed in Scilit:
- Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availabilityBMC Medicine, 2018
- The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authorsSystematic Reviews, 2018
- Redactions in protocols for drug trials: what industry sponsors concealedJournal of the Royal Society of Medicine, 2018
- Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patientsPLOS ONE, 2017
- Pharmaceutical companies’ policies on access to trial data, results, and methods: audit studyBMJ, 2017
- The Common Rule, UpdatedNew England Journal of Medicine, 2017
- Increasing value and reducing waste: addressing inaccessible researchThe Lancet, 2014
- European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial dataPharmaceutical Statistics, 2013
- The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu ExperiencePLOS Medicine, 2012
- Clinical Trial Registration: A Statement from the International Committee of Medical Journal EditorsNew England Journal of Medicine, 2004